1. Home
  2. COCP vs CCHH Comparison

COCP vs CCHH Comparison

Compare COCP & CCHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cocrystal Pharma Inc.

COCP

Cocrystal Pharma Inc.

N/A

Current Price

$1.01

Market Cap

19.2M

Sector

Health Care

ML Signal

N/A

Logo CCH Holdings Ltd Ordinary Shares

CCHH

CCH Holdings Ltd Ordinary Shares

N/A

Current Price

$0.89

Market Cap

17.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
COCP
CCHH
Founded
N/A
2015
Country
United States
Malaysia
Employees
10
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.2M
17.9M
IPO Year
2011
2025

Fundamental Metrics

Financial Performance
Metric
COCP
CCHH
Price
$1.01
$0.89
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
★ $8.00
N/A
AVG Volume (30 Days)
★ 33.0K
23.8K
Earning Date
11-13-2026
11-29-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 54.65
N/A
EPS
N/A
★ N/A
Revenue
★ $12,712,091.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$43.55
Revenue Growth
N/A
N/A
52 Week Low
$0.76
$0.18
52 Week High
$2.03
$15.39

Technical Indicators

Market Signals
Indicator
COCP
CCHH
Relative Strength Index (RSI) 43.22 43.58
Support Level $0.98 $0.86
Resistance Level $1.10 $1.08
Average True Range (ATR) 0.06 0.10
MACD 0.00 0.01
Stochastic Oscillator 42.57 22.56

Price Performance

Historical Comparison
COCP
CCHH

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). The company has one reportable and operating segment dedicated to the research and development company's novel orally administered antiviral influenza candidate. The company has pipeline products for diseases like : Influenza, Norovirus, Coronavirus, Respiratory Viruses, and Hepatitis C.

About CCHH CCH Holdings Ltd Ordinary Shares

CCH Holdings Ltd, through its subsidiaries, operates a specialty hotpot restaurant chain in Malaysia, specializing in chicken hotpot and fish head hotpot. The Group offers catering services in Malaysia and outside Malaysia, mainly under two brands, namely Chicken Claypot House for its chicken hotpot restaurants and Zi Wei Yuan for its fish head hotpot restaurants. It operates or licenses several restaurant outlets, among which include Chicken Claypot House, Zi Wei Yuan, 888 Family Food Courts, and other outlets under the Bibixian, Banbudian Bistro, and Chao Liu Xian Hotpot brands. A large share of its restaurants are located in Malaysia, with additional franchised outlets in Thailand, Indonesia, and China. Geographically, the Group's revenues are all derived from Malaysia.

Share on Social Networks: